Article
Author(s):
Patrick Mooney, vice president and head of Ophthalmology Franchise (US) at Novartis, offers an update on how the company is responding to the impact of the global coronavirus epidemic and the internal changes that have been implemented to ensure the safety and health of its employees.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.